Chlamydia pneumoniae: Inflammation and instability of the atherosclerotic plaque

Atherosclerosis

Volumn 140, Issue SUPPL. 1, 1998, Pages

  Gurfinkel, E ^a   Bozovich, G ^a  

^a HOSPITAL UNIVERSITARIO FUNDACIÓN FAVALORO   (Argentina)

Author keywords

Antibodies; Atherosclerotic plaque; Chlamydia pneumoniae; Myocardial; ROXIS study; Roxithromycin; Thrombosis; Unstable angina

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; HEPARIN; HLA ANTIGEN; LOW MOLECULAR WEIGHT HEPARIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PLACEBO; ROXITHROMYCIN;

ANTIGEN EXPRESSION; ATHEROSCLEROTIC PLAQUE; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CHRONIC INFLAMMATION; CLINICAL TRIAL; CONFERENCE PAPER; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; ISCHEMIC HEART DISEASE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; UNSTABLE ANGINA PECTORIS;

ANGINA, UNSTABLE; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CLINICAL TRIALS; CORONARY ARTERIOSCLEROSIS; HUMANS; INFLAMMATION;

EID: 0031728791     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00118-X     Document Type: Conference Paper

References (31)

1. Kruskal JB, Commerford PJ, Franks JJ, et al. Fibrin and fibrinogen-related antigens in patients with stable and unstable artery disease. New Engl J Med 1987;317:1361-5.
2. Theroux P, Latour JG, Leger-Gautier C, et al. Fibrinopeptide A plasma levels and platelet factor 4 levels in unstable angina pectoris. Circulation 1987;75:156-62.
3. Eisenberg PR, Sherman LA, Schechtman K, et al. Fibrinopeptide A: a marker of acute coronary thrombosis. Circulation 1985;71:912-8.
4. 2/ prothrombin 1+2 fragment and thrombin/antithrombin complex. Blood 1982;59:1086-97.
5. Gurfinkel E, Altman R, Rouvier J, et al. Significance of thrombosis and thrombolysis in silent myocardial ischaemia. Br Heart J 1994;71:151-5.
6. Krucoff MW, Wagner NB, Pope JE, et al. The portable programmable microprocessor-driven real-time 12-lead electrocardiographic monitor: preliminary report of a new device for the non invasive detection of successful reperfusion of silent coronary reocclusion. Am J Cardiol 1990;65:143-8.
7. Gurfinkel E, Bozovich G, Mejaíl I, et al. Time significance of acute thrombotic reactant markers in patients with and without silent myocardial ischemia and overt unstable angina. Am J Cardiol 1995;76:121-4.
8. US Department of Health and Human Services, Public Health Service Agency for Health Care Policy and Research National Heart, Lung, and Blood Institute. Unstable angina: diagnosis and management. Clinical Practice Guideline, vol. 10, 1994.
9. Lewis HDJ, Davis JW, Archibald DG, et al. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a veterans administration cooperative study. New Engl J Med 1983;309:396-9.
10. Theroux P, Water D, Qiu S, et al. Aspirin versus heparin to prevent myocardial infarction during the acute phase of unstable angina. Circulation 1993;88:2045-9.
11. Wallentin L, RISC group. Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. Lancet 1990;336:827-830.
12. Oler A, Whooley MA, Oler J, et al. Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina. JAMA 1996;276:811-5.
13. Theroux P, Quimet H, McCans J, et al. Aspirin, heparin, or both to treat acute unstable angina. New Engl J Med 1988;319:1105-11.
14. Cohen M, Adams P, Parry G, et al. Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in non prior aspirin users: primary endpoint analysis from the ATACS trial. Circulation 1994;89:81-8.
15. Gurfinkel EP, Manos EJ, Mejail R, et al. Low molecular weight heparin versus regular heparin or aspirin in the treatment of acute unstable angina and silent ischemia. J Am Coll Cardiol 1995;26:313-8.
16. The TIMI IIIB Investigators. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Circulation 1994;89:1545-56.
17. Theroux P, Waters DD, Lam J, et al. Reactivation of unstable angina following discontinuation of heparin. New Engl J Med 1992;327:141-5.
18. Granger CB, Miller JM, Bovill EG, et al. Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromes. Circulation 1995;91:1929-35.
19. Sylven C, Hagerman H, Karlsbery KE, et al. Platelet and leukocyte activation after myocardial infarction. Eur Heart J 1995;16:1800-6.
20. Moreno P, Fallen JT. Inflammation in acute coronary syndromes. In: Schultheiss HP, Schwimmbeck P, editors. The Role of Immune Mechanisms in Cardiovascular Disease. Berlin: Springer-Verlag, 1997:213-29.
21. Muhlestein JB, Hammond EH, Cariquist JF, et al. Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerosis versus other forms of cardiovascular disease. J Am Coll Cardiol 1996;27(7):1555-61.
22. Mazzone A, De Servi S, Ricevutti G, et al. Increased expression of neutrophil and monocyte adhesion molecules in unstable coronary artery disease. Circulation 1993;89(1):358-63.
23. Van der Wal AC, Becker A, et al. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994;89(1):3644.
24. Gurfinkel E, Raimondi E, Mejaíl I, et al. El sistema de histocompatibilidad mayor el fenomeno de la vulnerabilidad de la place ateromatosa en los sindromes agudos no Q. Potencial modulacion de la respuesta inflamatoria en la angina inestable. Rev Argent Cardiol 1997;65(1):57-60.
25. Saikku P, Leinonen M, Mattila K. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988;2:983-6.
26. Thom DH, Grayston JT, Siscovick DS, et al. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA 1992;268:68-72.
27. Gurfinkel E, Duronto E, Cerda E, et al. Patients with unstable angina related to C-reactive protein and Chlamydia pneumoniae infection. Eur Heart J 1996;17 (Suppl):578.
28. Gurfinkel E, Bozovich G, Daroca A, et al. for the ROXIS study group. Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study. Lancet 1997;350:404-7.
29. The Global use of Strategies of Open Occluded Coronary Arteries (GUSTO) IIB Investigators. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. New Engl J Med 1996;335:775-82.
30. Kadota JL. Non antibiotic effects of antibiotics. J Clin Microb Infect 1996;1(1):24-30.
31. Agen C, Danesi R, Blandizzi C, et al. Macrolide antibiotics as antiinflammatory agents: roxithromycin in an unexpected role. Agents Actions 1993;38:85-90.